American Water Works Co (AWK) Earnings Surpass Estimates with $1.15 Billion Revenue in 2Q

American Water Works Co on Smartkarma

Analysts on Smartkarma, such as Baptista Research, have been closely covering American Water Works Co with a bullish outlook. In a recent report titled “American Water Works Company: Initiation of Coverage – PFAS Regulatory Compliance,” Baptista Research highlighted the company’s strong start in 2023. The report indicated a rise in earnings per share (EPS) from $0.91 to $0.95 compared to the same quarter last year, in line with the company’s forecast. This increase was supported by factors like additional interest income related to the HOS sale, contributing to a positive earnings outlook for the full year.

A look at American Water Works Co Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma have assessed American Water Works Co‘s long-term outlook based on their Smart Scores system. The company has received a positive score in Growth and Momentum, indicating strong potential for future growth and market performance. With average scores in Value and Dividend, American Water Works Co is seen as a stable investment option with moderate returns in terms of value and dividends. However, the company scored lower in Resilience, suggesting a level of vulnerability to economic downturns or external shocks.

American Water Works Co. is known for providing drinking water, wastewater, and other water-related services across various states and regions, including Ontario, Canada. As a leading player in owning regulated water and wastewater utilities, the company serves a diverse customer base comprising residential, commercial, and industrial clients. While the company shows promise in growth and momentum, investors may need to consider the potential risks associated with its resilience score when evaluating their long-term investment strategies.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma